Ronan Levy - Field Trip Founder CEO
FTHWFDelisted Stock | USD 0.04 0.00 0.00% |
Insider
Ronan Levy is Founder CEO of Field Trip Health
Age | 43 |
Phone | 833-222-0084 |
Web | https://www.fieldtriphealth.com |
Similar Executives
Showing other executives | INSIDER Age | ||
Lena MoranAdams | Telix Pharmaceuticals Limited | N/A | |
Jyoti BappSc | Telix Pharmaceuticals Limited | N/A | |
Christine MBA | SAB Biotherapeutics | 69 | |
Christian Davis | Telix Pharmaceuticals Limited | N/A | |
MD MBA | MAIA Biotechnology | 55 | |
Theis MD | GH Research PLC | 48 | |
Andreas MD | Telix Pharmaceuticals Limited | N/A | |
Daniel Wadsworth | Arch Therapeutics | 69 | |
John Lynch | India Globalization Capital | N/A | |
Parag Mallick | Nautilus Biotechnology | 48 | |
BSc BSc | Telix Pharmaceuticals Limited | N/A | |
Kyung NamWortman | Cellectis SA | 53 | |
Terrence MD | Arch Therapeutics | 58 | |
M Mukunda | India Globalization Capital | N/A | |
Michael Abrams | Arch Therapeutics | 53 | |
Joseph McGuire | MAIA Biotechnology | 66 | |
Ana Stegic | Antibe Therapeutics | N/A | |
Dr MBA | Cellectis SA | 46 | |
MSc MSc | Cellectis SA | 54 | |
Anna Mowry | Nautilus Biotechnology | 41 | |
Kyahn Williamson | Telix Pharmaceuticals Limited | N/A |
Field Trip Health Leadership Team
Elected by the shareholders, the Field Trip's board of directors comprises two types of representatives: Field Trip inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Field. The board's role is to monitor Field Trip's management team and ensure that shareholders' interests are well served. Field Trip's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Field Trip's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ronan Levy, Founder CEO | ||
Chet Lakhani, VP Product | ||
Donna Wong, VP Inc | ||
Vicki Reed, Chief Officer | ||
Mujeeb Jafferi, Founder Pres | ||
Amardeep Manhas, Chief Officer | ||
Stacey Hoisak, Sr Counsel | ||
Edgar Diaz, VP Operations |
Field Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Field Trip a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Current Valuation | 19.22 M | |||
Shares Outstanding | 89.88 M | |||
Shares Owned By Insiders | 22.99 % | |||
Shares Owned By Institutions | 22.41 % | |||
Market Capitalization | 6.96 M |
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Consideration for investing in Field Pink Sheet
If you are still planning to invest in Field Trip Health check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Field Trip's history and understand the potential risks before investing.
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities |